- Home
- EJH vs GRI Comparison
EJH vs GRI Comparison
Compare EJH & GRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EJH
- GRI
- Stock Information
- Founded
- EJH 2018
- GRI 2018
- Country
- EJH China
- GRI United States
- Employees
- EJH N/A
- GRI N/A
- Industry
- EJH Other Consumer Services
- GRI Biotechnology: Pharmaceutical Preparations
- Sector
- EJH Consumer Discretionary
- GRI Health Care
- Exchange
- EJH Nasdaq
- GRI Nasdaq
- Market Cap
- EJH 4.8M
- GRI 5.6M
- IPO Year
- EJH 2021
- GRI N/A
- Fundamental
- Price
- EJH $0.59
- GRI $0.42
- Analyst Decision
- EJH
- GRI Strong Buy
- Analyst Count
- EJH 0
- GRI 2
- Target Price
- EJH N/A
- GRI $11.50
- AVG Volume (30 Days)
- EJH 1.4M
- GRI 181.8K
- Earning Date
- EJH 10-29-2024
- GRI 03-27-2025
- Dividend Yield
- EJH N/A
- GRI N/A
- EPS Growth
- EJH N/A
- GRI N/A
- EPS
- EJH N/A
- GRI N/A
- Revenue
- EJH $50,685,314.00
- GRI N/A
- Revenue This Year
- EJH N/A
- GRI N/A
- Revenue Next Year
- EJH N/A
- GRI N/A
- P/E Ratio
- EJH N/A
- GRI N/A
- Revenue Growth
- EJH N/A
- GRI N/A
- 52 Week Low
- EJH $0.53
- GRI $0.30
- 52 Week High
- EJH $36.70
- GRI $12.31
- Technical
- Relative Strength Index (RSI)
- EJH 43.66
- GRI 28.18
- Support Level
- EJH $0.58
- GRI $0.43
- Resistance Level
- EJH $0.64
- GRI $0.60
- Average True Range (ATR)
- EJH 0.08
- GRI 0.06
- MACD
- EJH -0.01
- GRI -0.00
- Stochastic Oscillator
- EJH 12.22
- GRI 10.91
About EJH E-Home Household Service Holdings Limited
E-Home Household Service Holdings Ltd is a household service company providing integrated household services through its website and WeChat platform across China. The company offers services including home appliance and housekeeping services. It operates its business mainly by receiving the orders online and providing the services offline. Its operations are organized into five reportable segments: installation and maintenance services, housekeeping services, senior care services, sales of pharmaceutical products and educational consulting services. The group's principal source of revenue comes from the Installation and Maintenance segment, followed by Housekeeping and Senior care services segment.
About GRI GRI Bio Inc.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist, for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.